TIAA CREF Investment Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$2.95M Buy
234,708
+74,495
+46% +$1.18M ﹤0.01% 1777
2018
Q4
$3.2M Buy
160,213
+23,376
+17% +$541K ﹤0.01% 1664
2018
Q3
$3.89M Sell
136,837
-11,201
-8% -$267K ﹤0.01% 1748
2018
Q2
$3.12M Buy
148,038
+17,388
+13% +$329K ﹤0.01% 1926
2018
Q1
$1.86M Buy
130,650
+5,556
+4% +$79.5K ﹤0.01% 2147
2017
Q4
$1.54M Sell
125,094
-1,425
-1% -$20.1K ﹤0.01% 2268
2017
Q3
$2.25M Buy
126,519
+22,680
+22% +$467K ﹤0.01% 2102
2017
Q2
$2.63M Buy
103,839
+65,132
+168% +$1.57M ﹤0.01% 2016
2017
Q1
$863K Sell
38,707
-3,379
-8% -$64.9K ﹤0.01% 2583
2016
Q4
$623K Sell
42,086
-1,580
-4% -$31.1K ﹤0.01% 2755
2016
Q3
$1.07K Buy
43,666
+931
+2% +$21.8K ﹤0.01% 2504
2016
Q2
$821K Buy
42,735
+3,462
+9% +$47.5K ﹤0.01% 2621
2016
Q1
$415K Hold
39,273
﹤0.01% 2836
2015
Q4
$476K Hold
39,273
﹤0.01% 2906
2015
Q3
$627K Buy
+39,273
New +$766K ﹤0.01% 2814

Other funds holding EVH

TIAA CREF Investment Management's EVH Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Evolent Health (EVH) stake by 46% in Q1 2019, buying an estimated $1.18M and bringing the position to 234,708 shares worth $2.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1777.

TIAA CREF Investment Management first reported a position in EVH in Q3 2015 and has held it in 15 quarters since. The position peaked at $3.89M in Q3 2018. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2019.

  • TIAA CREF Investment Management held 234,708 shares of Evolent Health worth $2.95M as of Q1 2019.
  • TIAA CREF Investment Management bought 74,495 Evolent Health shares in Q1 2019, an estimated $1.18M.
  • Evolent Health made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1777 holding.
  • TIAA CREF Investment Management first reported a position in Evolent Health in Q3 2015 and has held it in 15 quarters since.
  • TIAA CREF Investment Management's Evolent Health position peaked at $3.89M in Q3 2018.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.